Jacques D.
- Country
- France
- Department
- Hematology
Research Overview
- Phase 2 Study of Belantamab Mafodotin and Mezigdomide in Patients with Relapsed/Refractory Multiple Myeloma Following BCMA-Targeting CAR-T or Bispecific Antibody Therapy
- Evaluation of Luspatercept and Epoetin Alfa in Low-Risk Myelodysplastic Syndromes Without Ring Sideroblasts Post-Erythropoiesis-Stimulating Agent Failure
- Phase 3 Study of Isatuximab, Lenalidomide, and Dexamethasone ± Bortezomib in Non-Frail, Transplant-Ineligible Elderly Patients with Newly Diagnosed Multiple Myeloma
Data & Insights
Has run more than one trial at 65 of 167 partner sites.
Specializations
Myeloid Disorders
This investigator specializes in treating various myeloid conditions, with particular focus on Polycythemia Vera and Myelodysplastic Syndrome. Their research encompasses both high-risk and lower-risk manifestations of these disorders.
- Higher-risk MDS treatment approaches
- Polycythemia Vera management
- Chronic Myelomonocytic Leukemia interventions
Their work involves evaluating novel therapeutic combinations for these conditions, particularly in newly diagnosed patients.
Multiple Myeloma
The investigator has extensive involvement in multiple myeloma research, focusing on both newly diagnosed and relapsed cases. Their expertise extends to treating elderly and transplant-ineligible patients.
- Advanced relapsed/refractory myeloma therapy
- Elderly patient treatment protocols
- Novel therapeutic combinations
Their research encompasses various treatment durations and combination therapies for optimal patient outcomes.
Innovative Therapeutics
The investigator explores cutting-edge therapeutic approaches using novel agents such as luspatercept, venetoclax, and isatuximab across various hematologic conditions.
- Targeted therapy combinations
- Treatment resistance management
- Novel drug development
Their work includes evaluation of treatment efficacy in patients who have failed conventional therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.